Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study

被引：0
作者：
Beatriz Joven
Concepción Fito Manteca
Esteban Rubio
Enrique Raya
Alba Pérez
Raquel Hernández
Sara Manrique
Mercedes Núñez
Silvia Díaz-Cerezo
Sebastián Moyano
Alessandra Lacetera
Rosario García-Vicuña
机构：
[1] Hospital 12 de Octubre,Rheumatology Department
[2] Complejo Hospitalario de Navarra,Rheumatology Department
[3] Hospital Virgen del Rocío,Rheumatology Department
[4] Hospital Universitario Clínico San Cecilio de Granada,Rheumatology Department
[5] Rheumatology and Traumatology Department Hospital Puerta del Mar,Rheumatology Department
[6] Hospital Universitario de Valme,Rheumatology Department
[7] Hospital Carlos Haya,Medical Department
[8] Eli Lilly and Company,undefined
[9] OXON Epidemiology,undefined
[10] Hospital Universitario de la Princesa,undefined
[11] ISS-Princesa,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Psoriatic arthritis (PsA); Interleukin-17 inhibitors (anti-IL17); Secukinumab (SECU); Ixekizumab (IXE); Treatment patterns; Persistence; Real-world evidence (RWE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5415 / 5431
页数：16
相关论文
共 26 条
  • [1] Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
    Joven, Beatriz
    Fito Manteca, Concepcion
    Rubio, Esteban
    Raya, Enrique
    Perez, Alba
    Hernandez, Raquel
    Manrique, Sara
    Nunez, Mercedes
    Diaz-Cerezo, Silvia
    Moyano, Sebastian
    Lacetera, Alessandra
    Garcia-Vicuna, Rosario
    ADVANCES IN THERAPY, 2023, 40 (12) : 5415 - 5431
  • [2] Real-world persistence and treatment patterns in psoriatic arthritis patients treated with anti-1117 therapy: the PERFIL-17 study
    Joven Ibanez, B.
    Fito Manteca, C.
    Rubio, E.
    Raya, E.
    Perez-Linaza, A.
    Hernandeze, R.
    Manrique-Arija, S.
    Nunez, M.
    Diaz, S.
    Trancho, L.
    Garcia de Vicuna, R.
    Adler, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 78 - 78
  • [3] Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
    Alegre-Sancho, Juan Jose
    Nunez-Monje, Victoria
    Campos-Fernandez, Cristina
    Balaguer-Trull, Isabel
    Robustillo-Villarino, Montserrat
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Pedraz-Penalva, Teresa
    Pena-Gonzalez, Carolina
    de la Morena, Isabel
    Bedoya-Sanchis, Diego
    Yankova-Komsalova, Liliya
    Conesa-Mateos, Arantxa
    Martinez-Cristobal, Anna
    Navarro-Blasco, Francisco Javier
    Senabre-Gallego, Jose Miguel
    Sivera, Francisca
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors
    Mease, Philip J.
    Ferrante, Shannon A.
    Shiff, Natalie J.
    Fitzgerald, Timothy P.
    Chakravarty, Soumya D.
    Walsh, Jessica A.
    ADVANCES IN THERAPY, 2025, 42 (02) : 734 - 751
  • [5] Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
    Beatriz Joven
    Raquel Hernández Sánchez
    Eva Pérez-Pampín
    Ángel Aragón Díez
    Raquel Almodóvar
    Ángels Martínez-Ferrer
    Joaquín Belzunegui
    Esteban Rubio
    Silvia Díaz-Cerezo
    Sebastián Moyano
    Manuel Gómez-Barrera
    María Yébenes
    Mercedes Núñez
    Rheumatology and Therapy, 2023, 10 : 1319 - 1333
  • [6] Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
    Joven, Beatriz
    Sanchez, Raquel Hernandez
    Perez-Pampin, Eva
    Diez, Angel Aragon
    Almodovar, Raquel
    Martinez-Ferrer, Angels
    Belzunegui, Joaquin
    Rubio, Esteban
    Diaz-Cerezo, Silvia
    Moyano, Sebastian
    Gomez-Barrera, Manuel
    Yebenes, Maria
    Nunez, Mercedes
    RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1319 - 1333
  • [7] Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies
    Walsh, Jessica A.
    Cai, Qian
    Lin, Iris
    Fitzgerald, Timothy
    Pericone, Christopher D.
    Chakravarty, Soumya D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1245 - 1252
  • [8] Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
    Valero-Martinez, Cristina
    Urgelles, Judit Font
    Salles, Meritxell
    Joven-Ibanez, Beatriz E.
    de Juanes, Alexia
    Ramirez, Julio
    Juanola, Xavier
    Almodovar, Raquel
    Laiz, Ana
    Moreno, Mireia
    Pujol, Manel
    Beltran, Emma
    Pinto-Tasende, Jose Antonio
    Crespi, Laura
    Sala-Icardo, Luis
    Castaneda, Santos
    Garcia-Vicuna, Rosario
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity
    Murage, Mwangi J.
    Anderson, Amanda
    Casso, Deborah
    Oliveria, Susan A.
    Ojeh, Clement K.
    Muram, Talia M.
    Merola, Joseph F.
    Zbrozek, Art
    Araujo, Andre B.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 141 - 149
  • [10] Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study
    Philipp Sewerin
    Kathrin Borchert
    Dominic Meise
    Matthias Schneider
    Jörg Mahlich
    Rheumatology and Therapy, 2021, 8 : 483 - 497
123